Pacific Biosciences of California Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
/ 
Frequently asked questions
To buy Pacific Biosciences of California Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pacific Biosciences of California Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pacific Biosciences of California Inc. is PACB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pacific Biosciences of California Inc. has its primary listing on NASDAQ. You can trade Pacific Biosciences of California Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pacific Biosciences of California Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pacific Biosciences of California Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pacific Biosciences of California Inc..